Post by Nanotechnology Info & Statistics

RNA Interference Technology, Potential Treatment for Coronavirus Infection Alnylam Pharmaceuticals Inc., a biopharmaceutical company focusing on the research, development, and commercialization of RNA interference therapeutics for genetically defined diseases, in collaboration with Vir Biotechnology Inc., a clinical-stage immunology company specializing in the treatment and prevention of serious infectious diseases, are working to develop and commercialize an effective treatment for the new coronavirus disease (COVID-19) based on Alnylam’s proprietary small interfering RNA (siRNA) technology that directly targets highly conserved regions of coronavirus RNAs. https://bit.ly/39w6M8n #RNA #Technology #Coronavirus #Alnylam_Pharmaceuticals_Inc #biopharmaceutical #commercialization #diseases #Vir_Biotechnology_Inc #COVID_19 #siRNA #technology #StatNano #nanotechnology #NBIC